Today's PR stresses IPIX's discussions with 20+ pharmas for development partnerships, that it has already engaged a bulk manufacturer, and a possible $1B market for oral mucositis alone.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.